FoxO3a nuclear localization and its association with β-catenin and Smads in IFN-α-treated hepatocellular carcinoma...

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Interferon-α2b (IFN-α2b) exhibits antitumorigenic properties in hepatocellular carcinoma (HCC).
• The interaction between β-catenin, TCF4, and Smads is implicated in HCC cell proliferation and apoptosis.
• Forkhead box O-class 3a (FoxO3a) is a key regulator of cell proliferation and apoptosis, influenced by various kinases.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying IFN-α2b's effects on HCC cells.
• To investigate the role of FoxO3a in IFN-α2b-mediated reduction of proliferation and induction of apoptosis.
• To analyze the interplay between IFN-α2b, FoxO3a, β-catenin, and Smads signaling pathways.

Main Methods:

• Analysis of FoxO3a subcellular localization in IFN-α2b-stimulated HCC cell lines (HepG2/C3A, Huh7).
• Assessment of kinase activation (Akt, IKKβ, Erk, JNK, p38 MAPK) and their effect on FoxO3a.
• Co-immunoprecipitation assays to determine FoxO3a/β-catenin/Smads complex formation and FoxO3a target gene expression analysis.

Main Results:

• IFN-α2b treatment led to decreased cytosolic and increased nuclear FoxO3a levels.
• IFN-α2b modulated kinase activity, reducing Akt, IKKβ, Erk, and increasing JNK, p38 MAPK activation.
• p38 MAPK inhibition abrogated IFN-α2b-induced FoxO3a nuclear translocation; FoxO3a interacted with β-catenin and Smads, and mediated target gene induction.

Conclusions:

• IFN-α2b promotes FoxO3a nuclear accumulation and activity, potentially through p38 MAPK activation.
• A switch in β-catenin/Smads interaction from TCF4 to FoxO3a occurs upon IFN-α2b stimulation.
• FoxO3a acts as a critical mediator of IFN-α2b's antiproliferative and pro-apoptotic effects in HCC, highlighting novel therapeutic strategies.